Vicarious Surgical (RBOT) CTO and 10% owner sells 239 shares to cover taxes

Rhea-AI Filing Summary

Vicarious Surgical Inc. insider transaction: A reporting person who is a director, chief technology officer and 10% owner of Vicarious Surgical Inc. (RBOT) reported a small sale of Class A common stock. On 12/03/2025, the insider sold 239 shares of Class A common stock at a weighted average price of $2.97 per share, with individual trades ranging from $2.725 to $3.34 per share. After this transaction, the insider beneficially owns 33,623 shares directly. The sale was executed to cover tax withholding obligations arising from the vesting of restricted stock units granted on June 2, 2023, under the company’s equity incentive plan and is described as a mandatory "sell to cover" rather than a discretionary trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Khalifa Sammy

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/03/2025		S(1)		239	D	$2.97(2)	33,623	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

2. This figure is the weighted average sales price of multiple trades ranging from $2.725 to $3.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

	/s/ Sarah Romano, Attorney-in-Fact	12/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction was reported for Vicarious Surgical Inc. (RBOT)?

A director, chief technology officer and 10% owner of Vicarious Surgical Inc. (RBOT) reported selling 239 shares of Class A common stock on 12/03/2025.

At what price were the Vicarious Surgical (RBOT) shares sold in this Form 4 filing?

The insider sale had a weighted average price of $2.97 per share, based on multiple trades with prices ranging from $2.725 to $3.34 per share.

How many Vicarious Surgical (RBOT) shares does the insider own after this transaction?

Following the reported sale, the insider beneficially owns 33,623 shares of Vicarious Surgical Inc. Class A common stock directly.

Why did the Vicarious Surgical (RBOT) insider sell 239 shares?

The shares were sold to cover tax withholding obligations triggered by the vesting of restricted stock units granted on June 2, 2023 under the company’s equity incentive plan.

Was the Vicarious Surgical insider trade a discretionary sale?

No. The sale is described as being mandated by the issuer’s election under its equity incentive plan as a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

What additional pricing detail did the Vicarious Surgical (RBOT) insider provide?

The insider noted that the reported $2.97 figure is a weighted average of multiple trades between $2.725 and $3.34 per share and offered to provide exact trade breakdowns upon request.